Lobbying

Covid Patient Recovery Alliance's latest lobbying report covers Q2 2023, at $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Covid Patient Recovery Alliance

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Covid Patient Recovery Alliance lobbying by quarter
Covid Patient Recovery Alliance lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$01
Q2 2023$10K1
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$20K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health Resources & Services Administration (HRSA)2 reports
  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
Leavitt Partners$20K3 quarters

Former officials lobbying for it

Former position
JOSH TRENTChief Health Counsel for Chairman - House E&C Committee (E&C); Deputy Chief Health Counsel - E&C; Professional Staff - E&C; Health Care Policy Advisor - Senate; Deputy Director Office of Refugee Resettlement HHS; WH Office of Presidential PersonnelQ2 2023

Lobbying reports

Filed by
23/07/19for Q2 2023Leavitt Partners$10K
23/04/19for Q1 2023Leavitt PartnersUnder $5,000
23/01/17for Q4 2022Leavitt Partners$10K